Chronic suppurative lower airway infection is a hallmark feature of cystic fibrosis (CF).
Decades of experience in clinical microbiology have enabled the development of improved …

Although survival of individuals with cystic fibrosis (CF) has been continuously improving for
the past 40 years, respiratory failure secondary to recurrent pulmonary infections remains …

Cystic fibrosis (CF) is the most common lethal genetic disease in the Caucasian population,
and should be considered an infectious disease because of the basic pathophysiology …

Much of the improvement in the survival of individuals with cystic fibrosis (CF) is due to
advancements in antimicrobial treatments. New aerosolized antibiotic formulations have …

Infection of the airways remains the primary cause of morbidity and mortality in persons with
cystic fibrosis (CF). This review describes salient features of the epidemiologies of microbial …

Microbial communities characterize the airways of cystic fibrosis (CF) patients. Members of
these diverse and dynamic communities can be thought of as pathogens, benign …

A comprehensive understanding of airway infections offers the potential for improved
disease management in CF patients. Accurate quantitative microbiology will be a …

Progressive obstructive lung disease secondary to chronic airway infection, coupled with
impaired host immunity, is the leading cause of morbidity and mortality in cystic fibrosis (CF) …

Cystic fibrosis patients are exceptionally prone to colonisation by a narrow spectrum of
pathogenic bacteria. Since pulmonary infection presently, and for the foreseeable future …

In patients afflicted with cystic fibrosis (CF), morbidity and mortality are primarily associated
with the adverse consequences of chronic microbial bronchial infections, which are thought …